ArticleFrontiers in medicine2026

Comparison of the efficacy of low, moderate and standard doses of rituximab in the treatment of membranous nephropathy.

Mengling Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.